MYH3 and peripheral arterial disease: In KK-Ay PAD mice, no significant upregulation was observed in Myf5, Myogenin, or Myomaker mRNA levels compared with those in sham-operated mice, whereas the Gpr56 and Myh3 mRNA levels increased significantly (Table 2).